<SEC-DOCUMENT>0001513162-19-000091.txt : 20190409
<SEC-HEADER>0001513162-19-000091.hdr.sgml : 20190409
<ACCEPTANCE-DATETIME>20190409161515
ACCESSION NUMBER:		0001513162-19-000091
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20190405
ITEM INFORMATION:		Other Events
FILED AS OF DATE:		20190409
DATE AS OF CHANGE:		20190409

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIOMERICA INC
		CENTRAL INDEX KEY:			0000073290
		STANDARD INDUSTRIAL CLASSIFICATION:	DENTAL EQUIPMENT & SUPPLIES [3843]
		IRS NUMBER:				952645573
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0531

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37863
		FILM NUMBER:		19739620

	BUSINESS ADDRESS:	
		STREET 1:		17571 VON KARMAN AVENUE
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92614
		BUSINESS PHONE:		9496452111

	MAIL ADDRESS:	
		STREET 1:		17571 VON KARMAN AVENUE
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92614

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NMS PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19871130

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NUCLEAR MEDICAL SYSTEMS INC
		DATE OF NAME CHANGE:	19830216

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NUCLEAR INSTRUMENTS INC
		DATE OF NAME CHANGE:	19720508
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<head><title>Form 8-K</title> </head> <body style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman'; MARGIN-TOP:0px; COLOR:#000000"> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center>SECURITIES AND EXCHANGE COMMISSION</p> <p style=MARGIN:0px><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center>WASHINGTON, D.C.</p> <p style=MARGIN:0px><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center>FORM 8-K</p> <p style=MARGIN:0px><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center>CURRENT REPORT</p> <p style=MARGIN:0px><br></p> <p style=MARGIN:0px><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center>Pursuant to Section 13 or 15(d) of the</p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center>Securities Exchange Act of 1934</p> <p style=MARGIN:0px align=center><br> <table bordercolor=transparent cellspacing=0> <tr> <td style="BORDER-BOTTOM:#000000 1px solid"> <p align=center>&nbsp;April 5, 2019</p></td></tr> <tr> <td> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center>Date of Report (date of earliest event reported)</p></td></tr></table></p> <p style=MARGIN:0px align=center>&nbsp;</p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center><u>BIOMERICA, INC.</u></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center>(Exact Name of Registrant as Specified in its Charter)</p> <p style=MARGIN:0px><br></p> <div align=center><br> <table bordercolor=transparent cellspacing=0> <tr> <td style="BORDER-BOTTOM:#000000 1px solid"> <div align=center>Delaware</div></td> <td width=43 style=WIDTH:43px> <td style="BORDER-BOTTOM:#000000 1px solid"> <p align=center>0-8765</p></td> <td width=43 style=WIDTH:43px> <td style="BORDER-BOTTOM:#000000 1px solid"> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:-2px" align=center>95-2645573</p></td></tr> <tr> <td width=93 style=WIDTH:93px> <p>(State or Other Jurisdiction of Incorporation)</p></td> <td> <td width=83 style="WIDTH:83px; VERTICAL-ALIGN:top" valign=top>(Commission File Number)</td> <td> <td width=138 style="WIDTH:138px; VERTICAL-ALIGN:top" valign=top>(IRS Employer Identification Number)</td></tr></table></div> <p style=MARGIN:0px align=center><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center>17571 Von Karman Ave.</p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center><u>Irvine, California 92614</u></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center>(Address of Principal Executive Offices</p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center>Including Zip Code)</p> <p style=MARGIN:0px align=center><br></p> <p style=MARGIN:0px align=center><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center><u>949-645-2111</u></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center>(Registrant&#146;s Telephone Number,</p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center>Including Area Code)</p> <p style=MARGIN:0px align=center><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center>______________</p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center>(Former Name or Former Address if Changed</p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center>Since Last Report)</p> <p style=MARGIN:0px align=center><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center>Page 1 of 2 pages</p> <p style=MARGIN:0px align=center><br></p> <p style=MARGIN:0px align=center><br></p> <p style=MARGIN:0px align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"> </DIV> <br> <p /> <p style=MARGIN:0px align=center><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px"><b>Item 8.01 &nbsp;Other Events</b></p> <p style=MARGIN:0px><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px">Biomerica, Inc., has announced that the United States Patent and Trademark Office (&#147;USPTO&#148;) has issued a Notice of Allowance for the Company&#146;s InFoods<sup>&#174;</sup> Irritable Bowel Syndrome (&#147;IBS&#148;) product. This allowed application (#15/526,240) contains numerous claims that cover a product that enables physicians to identify patient specific foods that when removed from the diet may alleviate or improve an individual&#146;s IBS symptoms.</p> <p style=MARGIN:0px><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px">Following a Notice of Allowance, the process resulting in final issuance of a patent involves several administrative steps that are typically completed within a year.</p> <p style=MARGIN:0px align=center><br></p> <p style=MARGIN:0px align=center><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=justify>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p> <p style=MARGIN:0px align=center><br></p> <p style=MARGIN:0px align=center><br></p> <p style=MARGIN:0px><br></p> <p style=MARGIN:0px align=center><br></p> <p style=MARGIN:0px align=center><br></p> <p style=MARGIN:0px align=center><br></p> <p style=MARGIN:0px align=center><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px; PADDING-RIGHT:28px" align=center><u>SIGNATURES</u></p> <p style=MARGIN:0px><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px; PADDING-RIGHT:28px">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p> <p style=MARGIN:0px><br></p> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; WIDTH:240px; MARGIN-TOP:0px; FLOAT:left">Dated: &nbsp;April 9, 2019</p> <p style="FONT-SIZE:12pt; MARGIN:0px; PADDING-RIGHT:28px; TEXT-INDENT:-2px">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Biomerica, Inc.</p> <p style="CLEAR:left; MARGIN:0px"><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px; PADDING-RIGHT:28px; TEXT-INDENT:336px">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;By: <u>/s/ Zackary S. Irani</u></p> <p style="FONT-SIZE:12pt; MARGIN:0px; PADDING-RIGHT:28px; TEXT-INDENT:384px">Zackary S. Irani</p> <p style="FONT-SIZE:12pt; MARGIN:0px; PADDING-RIGHT:28px; TEXT-INDENT:384px">Chief Executive Officer</p> <p style=MARGIN:0px align=center><br></p> <p style=MARGIN:0px align=center><br></p> <p style=MARGIN:0px align=center><br><br></p></body>
<!-- EDGAR Validation Code: BF0A3017 -->
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
